ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

U L Medicines Limited

U L Medicines Limited is an active company incorporated on 21 February 2007 with the registered office located in London, Greater London. U L Medicines Limited was registered 18 years ago.
Status
Active
Active since incorporation
Company No
06120521
Private limited company
Age
18 years
Incorporated 21 February 2007
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 16 February 2025 (6 months ago)
Next confirmation dated 16 February 2026
Due by 2 March 2026 (5 months remaining)
Last change occurred 2 years 6 months ago
Accounts
Submitted
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Audit Exemption Subsidiary
Next accounts for period 30 June 2025
Due by 31 March 2026 (6 months remaining)
Contact
Address
25 Bedford Square
Bloomsbury
London
WC1B 3HH
United Kingdom
Same address for the past 4 years
Telephone
01923432688
Email
Available in Endole App
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • Group Financial Controller • British • Lives in England • Born in Apr 1970
Director • Swiss • Lives in Switzerland • Born in Jul 1964
Clinigen Pharma Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Idis Limited
Richard John Paling is a mutual person.
Active
Clinigen CTS Limited
Richard John Paling is a mutual person.
Active
Idis Group Limited
Richard John Paling is a mutual person.
Active
Idis Group Holdings Limited
Richard John Paling is a mutual person.
Active
Colonis Pharma Limited
Richard John Paling is a mutual person.
Active
Kinesys Consulting Limited
Richard John Paling is a mutual person.
Active
Clinigen Healthcare Limited
Richard John Paling is a mutual person.
Active
Clinigen Limited
Richard John Paling is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£595.56K
Same as previous period
Total Liabilities
-£89.61K
Same as previous period
Net Assets
£505.95K
Same as previous period
Debt Ratio (%)
15%
Same as previous period
Latest Activity
Subsidiary Accounts Submitted
5 Months Ago on 25 Mar 2025
Confirmation Submitted
6 Months Ago on 18 Feb 2025
Mr Richard Edward Adair Appointed
1 Year 4 Months Ago on 30 Apr 2024
Mr Jerome Marie Joseph Charton Appointed
1 Year 4 Months Ago on 30 Apr 2024
Subsidiary Accounts Submitted
1 Year 5 Months Ago on 8 Apr 2024
Confirmation Submitted
1 Year 6 Months Ago on 16 Feb 2024
David John Bryant Resigned
1 Year 7 Months Ago on 26 Jan 2024
Subsidiary Accounts Submitted
2 Years 4 Months Ago on 3 May 2023
Confirmation Submitted
2 Years 6 Months Ago on 21 Feb 2023
Amanda Miller Resigned
2 Years 7 Months Ago on 16 Jan 2023
Get Credit Report
Discover U L Medicines Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Consolidated accounts of parent company for subsidiary company period ending 30/06/24
Submitted on 25 Mar 2025
Audit exemption subsidiary accounts made up to 30 June 2024
Submitted on 25 Mar 2025
Notice of agreement to exemption from audit of accounts for period ending 30/06/24
Submitted on 25 Mar 2025
Audit exemption statement of guarantee by parent company for period ending 30/06/24
Submitted on 25 Mar 2025
Confirmation statement made on 16 February 2025 with no updates
Submitted on 18 Feb 2025
Second filing for the appointment of Mr Jerome Marie Joseph Charton as a director
Submitted on 13 Jul 2024
Appointment of Mr Jerome Marie Joseph Charton as a director on 30 April 2024
Submitted on 16 May 2024
Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024
Submitted on 16 May 2024
Audit exemption subsidiary accounts made up to 30 June 2023
Submitted on 8 Apr 2024
Audit exemption statement of guarantee by parent company for period ending 30/06/23
Submitted on 8 Apr 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year